Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 2811-2820 Newer>

Pharmaceutical Executive April 1, 2006 Christensen, McLaughlin & Wunker	The Road to Nowhere? More effective drugs? Another dead end. But patients open their wallets when a "good enough" drug gets better.
The Motley Fool April 4, 2006 Rich Duprey	Chiron's Booster Shot Novartis raises its bid for the biotech a second time, appeasing dissident shareholders.
The Motley Fool April 3, 2006 Rich Duprey	Merck Outclassed Class action status is granted to third parties -- like health insurance companies, HMOs, and unions -- in a Vioxx lawsuit. Investors, this is a disturbing development.
CIO April 1, 2006 Michael Fitzgerald	The Business Case for Paperless Medicine A strong argument can now be made that doctors in small and midsize practices should invest in electronic health records. Here's how to get your physicians on board.
Pharmaceutical Executive April 1, 2006 Matthew Kibby	Culture Clubs: Independent Ethics Committees Independent ethics committees sign off on patient-recruiting strategies around the world. Think laws and regulations shape their decisions? Think again.
Pharmaceutical Executive April 1, 2006 Sukys & Vernick	Direct to Consumer: Inspirational Insights Whether brand marketers are developing a current product or launching a new one, powerful consumer insights are what they need to get into the hearts and minds of their target consumers.
Pharmaceutical Executive April 1, 2006 David Duplay	Marketing to Professionals: A Sample Plan Sure, pharmaceutical e-sampling can save money. But there are plenty of other reasons to use it.
Pharmaceutical Executive April 1, 2006 Howard Steinberg	Alternative Media: TV's Targeted Comeback Educational TV programming provides a new channel of information for disease sufferers.
Pharmaceutical Executive April 1, 2006 Geoffrey M. Levitt	Meetings: Doctor Consultation The government's got its eye on consultant meetings. Are your company's policies strict enough?
Pharmaceutical Executive April 1, 2006 Jill Wechsler	Washington Report: A Warning Trend Washington's new answer to drug safety concerns is more warnings and more disclosure of undigested data. But warnings can go too far. Haven't FDA's critics ever heard the story of the boy who cried wolf?
<Older 2811-2820 Newer> Return to current articles.